Join the Defiants

Sign up to be the first to know about special offers and exciting Signos news.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
May 8, 2023
|
Podcast
|
3 min read
|
Written By
Bill Tancer

Ozempic, Wegovy, and Mounjaro: What You Need To Know

Signos-Body-Signals-Podcast-Image

On this episode of the Body Signos podcast, Host Bill Tancer is joined by Dr. William Dixon for a discussion about the latest weight loss drugs on the market.

They discuss:

  • What are GLP-1 agonists and how they work
  • Using GLP-1s for aesthetic vs. medically necessary reasons
  • What happens when you stop using them, and
  • The advantages of using Signos for maintaining healthy lifestyle habits whether you take these medications or not.

These and other fascinating insights on this episode of Body Signals.

‍

Topics discussed in this article:

Weight Loss for Women

References

Bill Tancer

Bill Tancer

Victoria Whittington earned her Bachelor of Science in Food and Nutrition from the University of Alabama and has over 10 years of experience in the health and fitness industry.

Table Of Contents
Text LinkText Link

Your body runs on glucose. Harness it with Signos.

Shop Now
HomeAboutScienceHow it WorksFAQsPricingBlogSupportCareersPartners

Don’t miss out!

Sign up to be the first to know about special offers and exciting Signos news.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Copyright © 2024 Signos Inc.
Terms and ConditionsPrivacy Policy

SIGNOS INDICATIONS: The Signos Glucose Monitoring System is an over-the-counter (OTC) mobile device application that receives data from an integrated Continuous Glucose Monitor (iCGM) sensor and is intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Signos Glucose Monitoring System helps to detect normal (euglycemic) and low or high (dysglycemic) glucose levels. The Signos Glucose Monitoring System may also help the user better understand how lifestyle and behavior modification, including diet and exercise, impact glucose excursions. This information may be useful in helping users to maintain a healthy weight.
The user is not intended to take medical action based on the device output without consultation with a qualified healthcare professional.
See user guide for important warnings and precautions.
STELO IMPORTANT INFORMATION: Consult your healthcare provider before making any medication adjustments based on your sensor readings and do not take any other medical action based on your sensor readings without consulting your healthcare provider. Do not use if you have problematic hypoglycemia. Failure to use Stelo and its components according to the instructions for use provided and to properly consider all indications, contraindications, warnings, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence. If your sensor readings are not consistent with your symptoms, a blood glucose meter may be an option as needed and consult your healthcare provider. Seek medical advice and attention when appropriate, including before making any medication adjustments and/or for any medical emergency.
STELO INDICATIONS FOR USE: The Stelo Glucose Biosensor System is an over-the-counter (OTC) integrated Continuous Glucose Monitor (iCGM) intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Stelo Glucose Biosensor System helps to detect normal (euglycemic) and low or high (dysglycemic) glucose levels. The Stelo Glucose Biosensor System may also help the user better understand how lifestyle and behavior modification, including diet and exercise,impact glucose excursion. The user is not intended to take medical action based on the device output without consultation with a qualified healthcare professional.